The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study

The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of hepatic and extrahepatic cancers, in particular those linked to obesity. In people with chronic liver disease, aspirin may confer protection against hepatocellular carcinoma (HCC). We explore t...

Full description

Bibliographic Details
Main Authors: Matthew Anson, Jun Shang Poon, Alex E. Henney, David Riley, Gema H. Ibarbaru, Cyril Sieberhagen, Daniel J. Cuthbertson, Uazman Alam, Theresa Hydes
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Medicine
Subjects:
Hepatocellular carcinoma
Non-alcoholic fatty liver disease
Aspirin
Anti-platelets
Obesity
Online Access:https://doi.org/10.1186/s12916-024-03802-4

Internet

https://doi.org/10.1186/s12916-024-03802-4

Similar Items